Tan; Fenlai

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tan; Fenlai.The latest application filed is for "stable polymorphic forms of compound as hypoxia mimetics, and uses thereof".

Company Profile

0.15.14

Tan; Fenlai - Beijing N/A CN
Tan; Fenlai - Troy MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Glucagon like peptide analogs, composition, and method of use Grant 9,487,570 - Hu , et al. November 8, 2	2016-11-08
Compound for increasing kinase active and application thereof Grant 9,409,900 - Kang , et al. August 9, 2	2016-08-09
Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof Grant 9,359,370 - Wang , et al. June 7, 2	2016-06-07
Substituted fused heterocycles as c-Met tyrosine kinase inhibitors Grant 9,242,991 - Hu , et al. January 26, 2	2016-01-26
Stable polymorphic forms of compound as hypoxia mimetics, and uses thereof Grant 9,238,637 - Kang , et al. January 19, 2	2016-01-19
Glucagon-like peptide-1 analogues and uses thereof Grant 8,951,959 - Wang , et al. February 10, 2	2015-02-10
Icotinib Hydrochloride, Synthesis, Crystalline Forms, Pharmaceutical Compositions, And Uses Thereof App 20140343082 - Wang; Yinxiang ; et al.	2014-11-20
Stable Polymorphic Forms of Compound as Hypoxia Mimetics, and Uses Thereof App 20140343137 - Kang; Xinshan ; et al.	2014-11-20
Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof Grant 8,822,482 - Wang , et al. September 2, 2	2014-09-02
Compounds as hypoxia mimetics, and compositions and uses thereof Grant 8,742,138 - Kang , et al. June 3, 2	2014-06-03
Compound For Increasing Kinase Active And Application Thereof App 20130225587 - Kang; Xinshan ; et al.	2013-08-29
Novel Glucagon Like Peptide Analogs, Composition, and Method of Use App 20130203672 - Hu; Shaojing ; et al.	2013-08-08
Novel Fused Heterocyclic Derivatives Useful as c-Met Tyrosine Kinase Inhibitors App 20130123286 - Hu; Shaojing ; et al.	2013-05-16
Glucagon-like Peptide-1 Analogues And Uses Thereof App 20130053304 - Wang; Yinxiang ; et al.	2013-02-28
Compounds As Hypoxia Mimetics, And Composiitons And Uses Thereof App 20120172399 - Kang; Xinshan ; et al.	2012-07-05
Icotinib Hydrochloride, Synthesis, Crystalline Forms, Pharmaceutical Compositions, and Uses Thereof App 20110182882 - Wang; Yinxiang ; et al.	2011-07-28
Novel Platinum Compounds For Treating Cancer App 20100152154 - Shaw; Jiajiu ; et al.	2010-06-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.